Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015475 |
---|---|
Receipt number | R000017987 |
Scientific Title | Phase I study of 5-FU + Oxaliplatin + Irinotecan + Levofolinate + Panitumumab as the first-line therapy in patients with KRAS or RAS wild-type metastatic colorectal cancer |
Date of disclosure of the study information | 2014/11/01 |
Last modified on | 2018/03/08 08:49:15 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/10/20 11:57:40 | ||
2 | Update | 2016/11/15 13:41:52 | Name of primary person or sponsor Organization Organization |
|
3 | Update | 2016/11/15 13:42:19 | Recruitment status Publication of results |
|
4 | Update | 2018/03/08 08:49:15 | Recruitment status Publication of results |